• From pterygium surgery tips to dangerous wineglasses, here’s a look at the year’s most-viewed interviews, surgical videos and 1-Minute Videos.
    Headline
    From recalls to regulatory approvals, here's a look at the year's most-viewed clinical news stories and Editors' Choice coverage.
    Headline
    Due to lack of sterility assurance, the FDA is urging healthcare professionals not to use sterile drug products produced and distributed by Ranier’s Compounding Laboratory, Ranier’s Pharmacy and Ranier’s RX Laboratory, Jeannette, Pennsylvania.
    Headline
    By Anni Griswold
    This week, a woman says she regrets her 25-year habit of sleeping with mascara, patients report satisfaction with Allergan’s hyaluronic acid filler and a mobile eye camp in Bangladesh serves 6,100 people in 6 days.
    Headline
    By Anni Griswold
    This week a crescent-shaped burn highlights the need for protective eyewear during solar eclipses, and fungal infections fall prey to a rose-colored eyedrop combined with green fluorescent light.
    Headline
    Vital Rx, Inc. d/b/a Atlantic Pharmacy and Compounding is voluntarily recalling all lots of its compounded injectable prescription medications due to lack of sterility assurance.
    Headline
    Whether you plan to take the Demonstration of Ophthalmic Cognitive Knowledge (DOCK) exam or participate in the new ABO Quarterly Questions pilot program, the Academy has the tools you'll need to ensure success.
    Headline
    The Centers for Medicare and Medicaid Services (CMS) offers a special bonus payment program for American Board of Ophthalmology-certified ophthalmologists who are participating in a combination of both Maintenance of Certification (MOC) and PQRS Reporting.
    Headline
    Allergan, Inc., reported $1.6 billion in total product net sales for the quarter ended March 31, an increase of 13 percent compared to the first quarter of 2013.
    Headline
    In an unusual partnership with activist investor William Ackman, Valeant Pharmaceuticals International Inc. this week proposed to buy Allergan Inc.
    Headline
    The FDA issued a reminder to health care providers not to administer any sterile products made and distributed by NuVision Pharmacy of Dallas because their sterility is not assured. This alert follows the FDA’s notice on May 18 recommending that health care providers…
    Headline
    Carl Zeiss Meditec announced a 2.9 percent increase in revenues, to 649.1 million euros, for the first nine months of the fiscal year compared to the same period of the previous year. The company reported a slight increase in its ophthalmic systems strategic business unit&r…
    Headline
    The FDA has announced a voluntary nationwide recall of all sterile use products produced and distributed by a Texas compounding pharmacy, Specialty Compounding in Cedar Park, Texas. The pharmacy is responding to reports of bacterial bloodstream infections potentially related…
    Headline
    Regeneron Pharmaceuticals this week reported positive results from two phase 3 trials of Eylea (aflibercept) injection for diabetic macular edema (DME). Treatment with the new anti-VEGF resulted in significantly greater improvement in BCVA compared with laser photocoagulatio…
    Headline
    Merck & Co, Inc., reported worldwide sales of $11.0 billion for the second quarter of 2013, a drop of 11 percent compared with the quarter a year earlier. The company said the decline in sales was due to patents expiring and a negative impact of foreign exchange rates.…
    Headline
    Ophthalmic company Nicox reported revenues of €0.2 million for the six months ended June 30, 2013, compared to €7.5 million for the same period of 2012. The French company’s revenues during the first half of 2013 correspond to the sales of AdenoPlus, a point…
    Headline
    STAAR Surgical Co. reported revenues of $18.2 million for the second quarter ended June 28, an increase of 14 percent over the second quarter of 2012. The results included sales of $11.3 million for the company's Visian ICL product portfolio and $5.9 million for its IOL prod…
    Headline
    Allergan, Inc., reported a 10.6 percent increase in total product net sales to $1,577.0 million for the second quarter ended June 30, compared to the second quarter of 2012. Net earnings attributable to Allergan were $359.9 million, up 21.7 percent. "In the second quarter,…
    Headline